Modern screening programs of breast cancer | Ukrainian Medical Journal

Materials and methods. An analysis of full-text publications was conducted, which were selected through a literature search in foreign databases (PubMed, Scopus, Lancet, ScienceDirect-Elsevier) and domestic databases for the period 2019–2024.

Results. An analytical review of the literature analyzed the experience of using screening programs and modern methods of diagnosing malignant breast tumors in Ukraine and abroad.

Conclusion. Measures for early (timely) detection of cancer of a given localization, primary and secondary prevention (through the introduction of modern screening programs, restoration of an effective system of preventive examinations of the population for the presence of oncological diseases), measures for dispensary monitoring of patients after surgical treatment will allow to achieve a significant reduction in mortality from breast cancer and medical care costs.

References

1. Злоякісні новоутворення молочної залози (2024) 2024 рік — уточнена інформація. Рак в Україні, 2022–2023. Захворюваність, смертність, показники діяльності онкологічної служби. Бюлетень національного канцер-реєстру України № 25. Київ. http://www.ncru.inf.ua/publications/BULL_25/index.htm.
2. Katsika L., Boureka E., Kalogiannidis I. et al. (2024) Screening for Breast Cancer: A Comparative Review of Guidelines. Life, 14(6): 777. DOI.org/10.3390/life14060777.
3. WHO (2014) WHO Guidelines Approved by the Guidelines Review Committee. WHO Position Paper on Mammography Screening. Switzerland, Geneva.
4. Siu A.L. Screening for Breast Cancer: U.S. (2016) Preventive Services Task Force Recommendation Statement. Ann. Intern. Med., 164(4): 279–296. doi.org/10.7326/m15-2886.
5. Oeffinger K.C., Fontham E.T., Etzioni R. et al. (2015) Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update from the American Cancer Society, 314(15): 1599–1614. doi.org/10.1001/jama.2015.12783.
6. Bevers T.B., Niell B.L., Baker J.L. et al. (2023) NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023. J. Natl. Compr. Cancer Netw., 21(9): 900–909. DOI: 10.6004/jnccn.2023.0046.
7. Committee on Practice Bulletins — Gynecology. Practice Bulletin Number 179 (2017) Breast Cancer Risk Assessment and Screening in Average-Risk Women. Obstet. Gynecol., 130: e1–e16.
8. Surgeons TASoB (2019) Position Statement on Screening Mammography. http://www.breastsurgeons.org/docs/statements/Position-Statement-on-Screening-Mammography.pdf.
9. Monticciolo D.L., Newell M.S., Hendrick R.E. et al. (2017) Breast Cancer Screening for Average-Risk Women: Recommendations from the ACR Commission on Breast Imaging. J. Am. Coll. Radiol., 14(9): 1137–1143. doi.org/10.1016/j.jacr.2017.06.001.
10. Beck A., Mls B.S. (2017) Breast Cancer Screening: Protocol for an Evidence Report to Inform an Update of the Canadian Task Force on Preventive Health Care 2011 Guidelines. canadiantaskforce.ca/wp-content/uploads/2017/09/BCU-protocol-14Mar2017-FINAL.pdf.
11. Schünemann H.J., Lerda D., Quinn C. et al. (2020) Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines. Ann. Intern. Med., 172(1): 46–56. doi.org/10.7326/m19-2125.
12. Cardoso F., Kyriakides S., Ohno S. et al. (2012) Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 30(8): 1194–1220. DOI: 10.1093/annonc/mdz173.
13. Harris M., Bennett J., Del Mar C.B. et al. (2009) Guidelines for Preventive Activities in General Practice. The Royal Australian College of General Practitioners. Sydney.
14. Hamashima C., Hamashima C.C., Hattori M. et al. (2016) The Japanese Guidelines for Breast Cancer Screening. Jpn. J. Clin. Oncol., 46(5): 482–492.
15. Bancej C., Decker K., Chiarelli A. et al. (2003) Contribution of clinical breast examination to mammography screening in the early detection of breast cancer. J. Med. Screen., 10(1): 16–21. DOI: 10.1258/096914103321610761.
16. Bobo J.K., Lee N.C., Thames S.F. (2000) Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. J. Natl. Cancer Inst., 92(12): 971–976. DOI: 10.1093/jnci/92.12.971.
17. Oestreicher N., White E., Lehman C.D. et al. (2002) Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Res. Treat., 76(1): 73–81.
18. Myers E.R., Moorman P., Gierisch J.M. et al. (2015) Benefits and Harms of Breast Cancer Screening: A Systematic Review. Jama, 314(15): 1615–1634.
19. Nelson H.D., Pappas M., Cantor A. et al. (2016) Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann. Intern. Med., 164(4): 256–267. doi.org/10.7326/m15-0970.
20. Bjurstam N.G., Björneld L.M., Duffy S.W. (2016) Updated results of the Gothenburg Trial of Mammographic Screening. Cancer, 122(12): 1832–1835.
21. Nyström L., Andersson I., Bjurstam N. et al. (2002) Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet, 359(9310): 909–919. doi.org/10.1016/s0140-6736(02)08020-0.
22. Tabar L., Duffy S.W., Yen M.F. et al. (2002) All-cause mortality among breast cancer patients in a screening trial: Support for breast cancer mortality as an end point. J. Med. Screen., 9(4): 159–162. doi.org/10.1136/jms.9.4.159.
23. Howlader N., Noone A.-M., Krapcho M. et al. (2014) SEER Cancer Statistics Review, 1975–2012; National Cancer Institute: Bethesda, MD, USA.
24. Breast Cancer Surveillance Consortium. Performance Measures for 1,838,372 Screening Mammography Examinations from 2004 to 2008 by Age-Based on BCSC Data through 2009.
25. Sima C.S., Panageas K.S., Schrag D. (2010) Cancer screening among patients with advanced cancer. Jama, 304(14): 1584–1591. doi.org/10.1001/jama.2010.1449.
26. Miglioretti D.L., Lange J., van den Broek J.J. et al. (2016) Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study. Ann. Intern. Med., 164(4): 205–214. doi.org/10.7326/m15-1241.
27. Sankaranarayanan R., Ramadas K., Thara S. et al. (2011) Clinical breast examination: Preliminary results from a cluster randomized controlled trial in India. J. Natl. Cancer Inst., 103(19): 1476–1480. doi.org/10.1093/jnci/djr304.
28. Brem R.F., Tabár L., Duffy S.W. et al. (2015) Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: The SomoInsight Study. Radiology, 274(3): 663–673.
29. Giuliano V., Giuliano C. (2013) Improved breast cancer detection in asymptomatic women using 3D-automated breast ultrasound in mammographically dense breasts. Clin. Imaging, 37(3): 480–486. DOI: 10.1016/j.clinimag.2012.09.018.
30. Kelly K.M., Dean J., Comulada W.S., Lee S.J. (2010) Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur. Radiol., 20(3): 734–742. doi.org/10.1007/s00330-009-1588-y.
31. Melnikow J., Fenton J.J., Whitlock E.P. et al. (2016) Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. In Supplemental Screening for Breast Cancer in Women with Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force. Agency for Healthcare Research and Quality (US).
32. Monticciolo D.L., Newell M.S., Moy L. et al. (2018) Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. J. Am. Coll. Radiol., 15(3): 408–414. doi.org/10.1016/j.jacr.2017.11.034.
33. Laws A., Katlin F., Hans M. et al. (2023) Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis. Ann. Surg. Oncol., 30(1): 68–77.
34. Warner E., Messersmith H., Causer P. et al. (2008) Systematic review: Using magnetic resonance imaging to screen women at high risk for breast cancer. Ann. Intern. Med., 148(9): 671–679.

Key words: .